JP2013503642A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013503642A5 JP2013503642A5 JP2012528058A JP2012528058A JP2013503642A5 JP 2013503642 A5 JP2013503642 A5 JP 2013503642A5 JP 2012528058 A JP2012528058 A JP 2012528058A JP 2012528058 A JP2012528058 A JP 2012528058A JP 2013503642 A5 JP2013503642 A5 JP 2013503642A5
- Authority
- JP
- Japan
- Prior art keywords
- interferon
- antibody
- subject
- cdna
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23963009P | 2009-09-03 | 2009-09-03 | |
| US61/239,630 | 2009-09-03 | ||
| PCT/US2010/047721 WO2011028933A1 (en) | 2009-09-03 | 2010-09-02 | Type 1 interferon diagnostic |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015075518A Division JP2015147788A (ja) | 2009-09-03 | 2015-04-02 | Ｉ型インターフェロン診断法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013503642A JP2013503642A (ja) | 2013-02-04 |
| JP2013503642A5 true JP2013503642A5 (enExample) | 2013-10-17 |
| JP5727484B2 JP5727484B2 (ja) | 2015-06-03 |
Family
ID=43649646
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012528058A Expired - Fee Related JP5727484B2 (ja) | 2009-09-03 | 2010-09-02 | Ｉ型インターフェロン診断法 |
| JP2015075518A Pending JP2015147788A (ja) | 2009-09-03 | 2015-04-02 | Ｉ型インターフェロン診断法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015075518A Pending JP2015147788A (ja) | 2009-09-03 | 2015-04-02 | Ｉ型インターフェロン診断法 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US20120251546A1 (enExample) |
| EP (1) | EP2473636B1 (enExample) |
| JP (2) | JP5727484B2 (enExample) |
| KR (1) | KR20120101340A (enExample) |
| CN (1) | CN102753704A (enExample) |
| AU (1) | AU2010289383B2 (enExample) |
| BR (1) | BR112012004781A2 (enExample) |
| CA (1) | CA2772921A1 (enExample) |
| CY (1) | CY1118566T1 (enExample) |
| DK (1) | DK2473636T3 (enExample) |
| ES (1) | ES2613055T3 (enExample) |
| HR (1) | HRP20170091T1 (enExample) |
| HU (1) | HUE032917T2 (enExample) |
| LT (1) | LT2473636T (enExample) |
| ME (1) | ME02599B (enExample) |
| MX (1) | MX2012002640A (enExample) |
| PL (1) | PL2473636T3 (enExample) |
| PT (1) | PT2473636T (enExample) |
| RS (1) | RS55641B1 (enExample) |
| RU (1) | RU2012112802A (enExample) |
| SI (1) | SI2473636T1 (enExample) |
| SM (2) | SMT201700063T1 (enExample) |
| WO (1) | WO2011028933A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2488632A1 (en) * | 2002-06-11 | 2003-12-18 | Idaho Research Foundation | Type i interferon-inducible proteins to detect viral infection |
| EP2712930A3 (en) * | 2006-12-06 | 2014-04-23 | MedImmune, LLC | Interferon alpha-induced pharmacodynamic markers |
| AU2008247398B2 (en) * | 2007-05-03 | 2013-10-10 | Medimmune, Llc | Interferon alpha-induced pharmacodynamic markers |
| EP2701742A4 (en) * | 2011-04-26 | 2015-03-18 | Genentech Inc | COMPOSITIONS AND METHOD FOR THE TREATMENT OF AUTOIMMUNE DISEASES |
| WO2013101771A2 (en) * | 2011-12-30 | 2013-07-04 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
| KR102320059B1 (ko) * | 2012-06-13 | 2021-11-01 | 아스트라제네카 아베 | 항-i형 인터페론 수용체(ifnar) 항체에 대한 고정 투여 계획 |
| JP6531306B2 (ja) * | 2015-02-20 | 2019-06-19 | 一三 西野 | 炎症性筋疾患鑑別マーカー及びそれを用いた炎症性筋疾患と非炎症性筋疾患の鑑別方法 |
| CN105316404B (zh) * | 2015-02-27 | 2017-02-22 | 中南大学湘雅二医院 | 系统性红斑狼疮生物标志物及其诊断试剂盒 |
| US11072652B2 (en) | 2016-03-10 | 2021-07-27 | Viela Bio, Inc. | ILT7 binding molecules and methods of using the same |
| CN105567861B (zh) * | 2016-03-16 | 2018-12-14 | 宫蕊 | Ifi27作为冠心病诊断标志物的用途 |
| BR112021015596A2 (pt) * | 2019-02-15 | 2021-10-05 | Astrazeneca Ab | Distúrbios mediados pelo interferon tipo i |
| HUE070947T2 (hu) | 2019-11-11 | 2025-07-28 | Astrazeneca Ab | I-es típusú interferon gátlása szisztémás lupus erythematosusban |
| EP4566667A3 (en) | 2020-05-29 | 2025-09-03 | AstraZeneca AB | Treatment of cardiometabolic disease with inhibitors of type i interferon signalling |
| CN116234553A (zh) * | 2020-10-02 | 2023-06-06 | 新基公司 | 治疗系统性红斑狼疮的方法和作为对疗法临床敏感性的预测指标的生物标志物的用途 |
| TW202237647A (zh) | 2020-10-08 | 2022-10-01 | 瑞典商阿斯特捷利康公司 | 狼瘡發作之治療 |
| CN116997359A (zh) | 2020-11-18 | 2023-11-03 | 阿斯利康(瑞典)有限公司 | 类固醇节制 |
| BR112023021868A2 (pt) | 2021-04-23 | 2023-12-19 | Astrazeneca Ab | Tratamento de lúpus eritematoso cutâneo |
| WO2022223771A1 (en) | 2021-04-23 | 2022-10-27 | Astrazeneca Ab | Treatment of lupus nephritis with anti-type i inf receptor antibody anifrolumab |
| RS64821B1 (sr) | 2021-04-23 | 2023-12-29 | Astrazeneca Ab | Režim doziranja anti-ifnar1 za subkutane injekcije |
| US20240287176A1 (en) * | 2021-05-04 | 2024-08-29 | Viela Bio, Inc. | Methods of treatment of autoimmune disorders using ilt7 binding proteins |
| EP4337696A1 (en) | 2021-05-12 | 2024-03-20 | Astrazeneca AB | Inhibitor of type 1 interferon receptor steroid sparing in systemic lupus erythematosus patients |
| IL310241A (en) | 2021-07-27 | 2024-03-01 | Astrazeneca Ab | Lupus treatment |
| US20250122294A1 (en) | 2021-10-04 | 2025-04-17 | Astrazeneca Ab | Treatment of lupus |
| EP4587005A1 (en) | 2022-09-14 | 2025-07-23 | Viatris Asia Pacific Pte. Ltd. | Sip 1 receptor modulators for use in the treatment of type 1 ifn mediated diseases |
| WO2024079241A1 (en) | 2022-10-13 | 2024-04-18 | Astrazeneca Ab | Treatment of lupus |
| IL324676A (en) | 2023-05-19 | 2026-01-01 | Astrazeneca Ab | Lupus treatment |
| WO2025022280A1 (en) | 2023-07-21 | 2025-01-30 | Astrazeneca Ab | Treatment of neurodegenerative diseases |
| GB202315831D0 (en) | 2023-10-16 | 2023-11-29 | Astrazeneca Ab | Treatment of skin disease |
| GB202402824D0 (en) | 2024-02-28 | 2024-04-10 | Astrazeneca Ab | Treatment of chronic kidney disease |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8303165D0 (en) | 1983-02-04 | 1983-03-09 | Secher D S | Monoclonal antibody |
| EP0139676B1 (en) | 1983-02-04 | 1992-11-25 | Cytoclonal Pharmaceutics Inc. | Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins |
| DE3306060A1 (de) | 1983-02-22 | 1984-08-23 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung |
| ATE78262T1 (de) | 1985-06-11 | 1992-08-15 | Ciba Geigy Ag | Hybrid-interferone. |
| US7247425B2 (en) * | 1998-01-30 | 2007-07-24 | Evolutionary Genomics, Llc | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| US7087726B2 (en) | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
| JP2008500009A (ja) * | 2003-03-03 | 2008-01-10 | ジェネンテック・インコーポレーテッド | 全身性エリテマトーデスの治療のための組成物と方法 |
| CA2458085A1 (en) * | 2003-03-21 | 2004-09-21 | F. Hoffmann-La Roche Ag | Transcriptional activity assay |
| US7619070B2 (en) | 2003-04-23 | 2009-11-17 | Medarex, Inc. | Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) |
| KR101151477B1 (ko) | 2003-12-10 | 2012-06-22 | 메다렉스, 인코포레이티드 | 인터페론 알파 항체 및 그의 용도 |
| WO2005086891A2 (en) * | 2004-03-05 | 2005-09-22 | Rosetta Inpharmatics Llc | Classification of breast cancer patients using a combination of clinical criteria and informative genesets |
| JP5160887B2 (ja) | 2004-06-21 | 2013-03-13 | メダレックス インコーポレイテッド | インターフェロンアルファレセプター１抗体及びその使用法 |
| US20070092890A1 (en) * | 2005-08-05 | 2007-04-26 | Genentech, Inc. | Methods and compositions for detecting autoimmune disorders |
| US8211649B2 (en) * | 2006-03-31 | 2012-07-03 | Human Genome Sciences, Inc. | Methods of diagnosing and prognosing hodgkin's lymphoma |
| US20100120627A1 (en) * | 2006-08-02 | 2010-05-13 | Abdelmajid Belouchi | Genemap of the human genes associated with psoriasis |
| EP2712930A3 (en) * | 2006-12-06 | 2014-04-23 | MedImmune, LLC | Interferon alpha-induced pharmacodynamic markers |
| AU2008247398B2 (en) * | 2007-05-03 | 2013-10-10 | Medimmune, Llc | Interferon alpha-induced pharmacodynamic markers |
| US20100209914A1 (en) * | 2007-05-25 | 2010-08-19 | Ore Pharmaceuticals , Inc. | Methods, systems, and kits for evaluating multiple sclerosis |
| CA2714410A1 (en) * | 2008-02-08 | 2009-08-13 | Medimmune, Llc | Disease markers and uses thereof |
| WO2009130176A1 (en) * | 2008-04-21 | 2009-10-29 | Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Antiviral Therapy |
| US20090325176A1 (en) * | 2008-06-05 | 2009-12-31 | Wyeth | Gene Expression Profiles Associated with Asthma Exacerbation Attacks |
-
2010
- 2010-09-02 US US13/393,616 patent/US20120251546A1/en not_active Abandoned
- 2010-09-02 SI SI201031376A patent/SI2473636T1/sl unknown
- 2010-09-02 RU RU2012112802/10A patent/RU2012112802A/ru not_active Application Discontinuation
- 2010-09-02 MX MX2012002640A patent/MX2012002640A/es not_active Application Discontinuation
- 2010-09-02 BR BR112012004781A patent/BR112012004781A2/pt not_active IP Right Cessation
- 2010-09-02 CA CA2772921A patent/CA2772921A1/en not_active Abandoned
- 2010-09-02 ME MEP-2017-24A patent/ME02599B/me unknown
- 2010-09-02 PT PT108145137T patent/PT2473636T/pt unknown
- 2010-09-02 JP JP2012528058A patent/JP5727484B2/ja not_active Expired - Fee Related
- 2010-09-02 WO PCT/US2010/047721 patent/WO2011028933A1/en not_active Ceased
- 2010-09-02 ES ES10814513.7T patent/ES2613055T3/es active Active
- 2010-09-02 HR HRP20170091TT patent/HRP20170091T1/hr unknown
- 2010-09-02 SM SM20170063T patent/SMT201700063T1/it unknown
- 2010-09-02 EP EP10814513.7A patent/EP2473636B1/en active Active
- 2010-09-02 KR KR1020127008547A patent/KR20120101340A/ko not_active Withdrawn
- 2010-09-02 PL PL10814513T patent/PL2473636T3/pl unknown
- 2010-09-02 RS RS20170089A patent/RS55641B1/sr unknown
- 2010-09-02 AU AU2010289383A patent/AU2010289383B2/en not_active Ceased
- 2010-09-02 LT LTEP10814513.7T patent/LT2473636T/lt unknown
- 2010-09-02 HU HUE10814513A patent/HUE032917T2/hu unknown
- 2010-09-02 DK DK10814513.7T patent/DK2473636T3/en active
- 2010-09-02 CN CN2010800447566A patent/CN102753704A/zh active Pending
-
2015
- 2015-03-18 US US14/662,134 patent/US20150191788A1/en not_active Abandoned
- 2015-04-02 JP JP2015075518A patent/JP2015147788A/ja active Pending
- 2015-10-06 US US14/876,549 patent/US20160024205A1/en not_active Abandoned
-
2017
- 2017-01-26 SM SM201700063T patent/SMT201700063B/it unknown
- 2017-01-26 CY CY20171100112T patent/CY1118566T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013503642A5 (enExample) | ||
| HRP20170091T1 (hr) | Dijagnostika interferona tip 1 | |
| JP2012518421A5 (enExample) | ||
| JP2010529857A5 (enExample) | ||
| JP2019196400A5 (enExample) | ||
| JP2012531202A5 (enExample) | ||
| EP2603605B1 (en) | A method for classifying an inflammatory bowel disease as a crohn's disease or as an ulcerative colitis | |
| JP2010526107A5 (enExample) | ||
| JP2014509862A5 (enExample) | ||
| JP2011101652A5 (enExample) | ||
| JP2020505920A5 (enExample) | ||
| JP2017510244A5 (enExample) | ||
| JP2010535480A5 (enExample) | ||
| JP2009523005A5 (enExample) | ||
| JP2012514451A5 (enExample) | ||
| JP2013505020A5 (enExample) | ||
| MX346956B (es) | Captura directa, amplificación y secuenciación de objetivo adn usando cebadores inmovilizados. | |
| JP2012503985A5 (enExample) | ||
| JP2010035552A5 (enExample) | ||
| JP2009544314A5 (enExample) | ||
| JP2015091235A5 (enExample) | ||
| WO2006029184A3 (en) | Genes useful for diagnosing and monitoring inflammation related disorders | |
| JP2006518186A5 (enExample) | ||
| JP2017521654A5 (enExample) | ||
| JP2005511023A5 (enExample) |